MentionFox
Home › Who owns › Twist Bioscience Corp
Owners, funding and legal record

Who owns Twist Bioscience Corp? Owners, funding and legal record

Before you sign with, sell to or invest in Twist Bioscience Corp

MentionFox check on Twist Bioscience Corp: no red flags found in 12 sources (checked 6 November 2026). mentionfox.com/c/who-owns/twist-bioscience

Check Twist Bioscience Corp before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Twist Bioscience Corp?

Twist Bioscience Corp is a publicly traded company (Nasdaq: TWST). The most recent 5%+ ownership report names Fidelity (FMR) holding 14.4% (Schedule 13G/A, filed 2026-11-05).

As of November 6, 2026, Twist Bioscience Corp is a publicly traded company (Nasdaq: TWST); its largest reported holder is Fidelity (FMR), with 14.4% on Schedule 13G/A of November 5, 2026, then Artisan Partners Asset Management Inc. (7.7%) (Schedule 13G/A, November 5, 2026).

EdgePoint Investment Group Inc. also filed stake reports on 11 other companies ↓

Is this your company?

About to sign with, pay or invest in Twist Bioscience Corp? See the free Snapshot first.

Watch Twist Bioscience Corp

Free to see. No signup.

Is Twist Bioscience Corp a real, registered company?

Before you sign or pay

Who are Twist Bioscience Corp's owners and officers?

Twist Bioscience Corp: incorporated in Delaware; business address in South San Francisco, California; industry Biological Products, (No Diagnostic Substances) (Schedule 13G/A, 2026-11-05).

ReportHolderShare
Schedule 13G/A, 2026-11-05Fmr LLC14.4%
Schedule 13G/A, 2026-09-08Ark Investment Management LLC5.11%
Schedule 13G/A, 2026-09-08Fmr LLC13.2%
Schedule 13G/A, 2026-08-14Edgepoint Investment Group Inc.4.21%
Schedule 13G, 2026-08-14T. Rowe Price Associates, Inc.5.8%
Schedule 13G/A, 2026-08-14Ark Investment Management LLC7.31%
Schedule 13G/A, 2026-08-13Artisan Partners Asset Management Inc.7.7%
Schedule 13G/A, 2026-08-11William Blair Investment Management, LLC3.5%
Schedule 13G, 2026-08-06Fmr LLC7.6%
Schedule 13G/A, 2026-05-07William Blair Investment Management, LLC8.6%
Schedule 13G/A, 2026-04-30Ark Investment Management LLC10.35%
Schedule 13G, 2026-04-30Vanguard Capital Management5.05%

Questions about who owns Twist Bioscience Corp

Who owns Twist Bioscience Corp?

On this page, 5 holders' latest ownership filings report 5% or more of Twist Bioscience Corp: Fmr LLC (14.4%, Schedule 13G/A, filed 2026-11-05), Artisan Partners Asset Management Inc. (7.7%, Schedule 13G/A, filed 2026-08-13), T. Rowe Price Associates, Inc. (5.8%, Schedule 13G, filed 2026-08-14), Ark Investment Management LLC (5.11%, Schedule 13G/A, filed 2026-09-08) and Vanguard Capital Management (5.05%, Schedule 13G, filed 2026-04-30).

Who are the largest shareholders of Twist Bioscience Corp?

By the share each holder's latest filing reports, the largest holders of Twist Bioscience Corp on this page are Fmr LLC (14.4%), Artisan Partners Asset Management Inc. (7.7%) and T. Rowe Price Associates, Inc. (5.8%).

When did Fmr LLC buy into Twist Bioscience Corp?

The filings give report dates, not purchase dates. The earliest filing from Fmr LLC on this page is the Schedule 13G, filed 2026-08-06, reporting 7.6%; its latest, Schedule 13G/A filed 2026-11-05, reports 14.4%.

Is this an audit or a full list?

Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.

Want the whole picture on Twist Bioscience Corp?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Twist Bioscience Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Twist Bioscience Corp covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    18 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Which insiders own Twist Bioscience Corp shares?

Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.

Shares outstanding: 62,707,424 as of 2026-07-29, from the company's latest SEC cover page.

How much has Twist Bioscience Corp raised?

No fundraising or offering filing from Twist Bioscience Corp is on file with us.

Keep reading

More on Twist Bioscience Corp and the records around it.

Twist Bioscience Corp elsewhere on the record

Companies that share a holder

Related pages

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

Not for employment, credit, insurance or tenancy decisions.

Cite this page

Permanent URL: https://mentionfox.com/who-owns/twist-bioscience
Last updated 2026-11-06
Who owns Twist Bioscience? Publicly traded (Nasdaq: TWST). MentionFox, 2026-11-06. https://mentionfox.com/who-owns/twist-bioscience